HOVON HO44

• Ziektebeeld:
• Verrichter: HOVON

Titel:
A randomized phase III study on the effect of the chimeric anti-CD20 monoclonal antibody (MabThera) during sequential chemotherapy followed by autologous stem cell transplantation in patients with relapsed or progressive B-cell non-Hodgkin's lymphoma.